Synopsis
Ion channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting this gene family have been discovered for diseases such as hypertension, epilepsy, and neuropathic pain. This symposium, the 8th in an ongoing series, will showcase the most recent advances to aid the design of new ion channel therapeutics and promote interaction between scientists with a shared interest in the field of ion channel drug discovery.
•
Medicinal chemistry case studies of ion channels as therapeutic targets
•
Advances in structure determination techniques and successful structure determinations of key ion channels
•
Novel pharmacology and target validation
•
Emerging technologies for targeting, assaying and modulating ion channel targets.
Attendees
This event will be relevant to scientists from industry and academia interested in the therapeutic potential of ion channels. The organising committee particularly welcomes attendance and participation of students or early career researchers working in the field of ion channels.
Programme
To view the confirmed speakers click
here.
Exhibitors and Sponsors
For further information and prices please contact events@hg3.co.uk.
Accessibility Grants
SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.
Venue and Contact
Organising committee
Rose Bardell-Cox, Evotec
Michael Clegg, MSD
Brian Cox, University of Sussex
Sarah Major, Dark Blue Therapeutics
Alex Preston, GSK
Jason Tierney, MedChemica